CAMEO+ eventCORPORATE2026-04-27馃嚭馃嚫
Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion
source: Eli Lilly -> target: Ajax Therapeutics
On 2026-04-27, Eli Lilly said it would buy privately held Ajax Therapeutics for up to $2.3 billion in cash. The deal targets Ajax's experimental oral treatment for myelofibrosis and is intended to advance it into larger trials.
0.34Significance7.0Magnitude0.5Systemic0.6Market1Articles
Location
IndianapolisIndianaNorth AmericaUnited StatesNorth America39.768, -86.158
Story Links